Medical therapy for conjunctivitis. Literature review

Author:

Trubilin V. N.1,Poluninа E. G.1ORCID,Kozhukhov A. A.1,Kurenkov V. V.2,Moreva N. V.3,Trubilin A. V.1

Affiliation:

1. Academy of Postgraduate Education of the Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of Federal Medical Biological Agency of Russia

2. Ophthalmology Clinic of Dr. Kurenkov

3. City Clinical Hospital No. 3

Abstract

Conjunctivitis, according to various studies, is the most common reason for going to the initial outpatient appointment and can be caused by several factors at the same time. Treatment is carried out comprehensively, depending on the clinical picture, somatic status and anamnesis data. In accordance with the clinical guidelines developed by the Russian Association of Ophthalmologists, the following groups of drugs are recommended for use: antibacterial, antiseptic, antihistamine, nonsteroidal anti-inflammatory drugs.Purpose: to analyze the use of the above groups of drugs in the treatment of conjunctivitis in order to recommend a reasonable prescription of the necessary therapy.Materials and methods. The literature data on the study of the features of the action of the above pharmacological groups in the treatment of conjunctivitis, obtained on the resources of PubMed, eLibrary, Crossref Metadata, mainly over the past 20 years, are presented.Results. The presence of signs of an allergic reaction involves the appointment of antiallergic drugs with multiple pharmacological effects – blockade of histamine receptors, stabilization of mast cell membranes and suppression of eosinophil filtration. Given the different mechanisms of action within this group of drugs, it is necessary to select them individually. When prescribing tablet forms of antihistamines, it must be remembered that with prolonged use, they can cause patients to feel dry in their eyes. In cases where the above antiallergic drugs do not adequately control the allergic inflammatory process, anti-inflammatory drugs are used. Nonsteroidal and steroid anti-inflammatory drugs are used as anti-inflammatory drugs. Usually nonsteroidal anti-inflammatory drugs are recommended for use in chronic conjunctivitis and patients with a history of systemic diseases. Steroid drugs are indicated for severe forms of manifestation of the allergic process on the eyes, as well as the appointment of steroid anti-inflammatory drugs is recommended for use in short courses (up to 2 weeks), and with their longer use, control of intraocular pressure is necessary. Literature data indicate the lack of efficacy of antiviral drugs such as acyclovir and others from this group in the treatment of conjunctivitis of adenoviral etiology. Drugs with an immunomodulatory effect based on interferon or inducers of interferon synthesis are widely used. The prescription of antibiotics should be justified, since in recent years the level of resistance to them has significantly increased. Antiseptics that have a wide spectrum of action (bacteria, viruses, fungi and protozoa) are an alternative to antibiotics, but it must be remembered that this group of drugs often causes allergic reactions.Conclusion. The treatment of conjunctivitis must be approached carefully, taking into account not only the etiology of the disease, but also the somatic and immune status of the patient. To avoid the negative effects of the use of antibiotics, replace them with alternative drugs and do not use them in the treatment of conjunctivitis of a non-bacterial nature.

Publisher

Academy of Medical Optics and Optometry

Subject

General Medicine

Reference34 articles.

1. Granet D. Allergic rhinoconjunctivitis and differential diagnosis of the red eye. Allergy Asthma Proc. 2008;29(6):565–574. https://doi.org/10.2500/aap.2008.29.3170

2. Yu K., Bunya V., Maguire M., Asbell P., Ying G.S. Dry Eye Assessment and Management Study Research Group. Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study. Ophthalmology. 2021;128(10):1384–1392. https://doi.org/10.1016/j.ophtha.2021.03.030

3. Zhemchugova A.V., Kurenkov V.V., Polunin G.S., Polunina E.G., Alieva A., Martirosova N.I. The therapeutic eyelids hygiene for prophylaxis and treatment complications caused by change of microflora and tear production after refractive surgery. Ophthalmology in Russia. 2012;9(1):18–22. (In Russ.) https://doi.org/10.18008/1816-5095-2012-1-18-22

4. Trubilin V.N., Polunina E.G., Kozhukhov A.A., Kurenkov V., Moreva N.V., Trubilin A.V., Chinenova K.V. Differential Diagnostic Indicators for the Appointment of NonSteroidal Anti-Inflammatory Therapy in the Treatment of Red Eye Syndrome at the Stage of Primary Outpatient Admission. Ophthalmology in Russia. 2023;20(2):332–340. https://doi.org/10.18008/1816-5095-2023-2-332-340

5. Clinical recommendations “Conjunctivitis” approved by the Ministry of Health of Russia. (In Russ.) URL: https://legalacts.ru/doc/klinicheskie-rekomendatsii-koniunktivitutv-minzdravom-rossii/ (accessed: 18.12.2022).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3